Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
2023 · Nature Medicine · 442 citations
https://doi.org/10.1038/s41591-023-02371-y
A
Ansam Sinjab
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
2.1K
Citations
18
h-index
25
i10-index
Ansam Sinjab is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers & RNA modifications and cancer. The author has an h-index of 18, co-authored 103 publications.
ORCID: 0000-0001-5777-227XPapers by this author
worksNeoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
2023 · Nature Medicine · 193 citations
https://doi.org/10.1038/s41591-022-02189-0
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma
2022 · Cancer Discovery · 145 citations
https://doi.org/10.1158/2159-8290.cd-21-1658
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
2024 · Nature Communications · 19 citations
https://doi.org/10.1038/s41467-024-51708-9
Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes
2022 · International Journal of Molecular Sciences · 14 citations
https://doi.org/10.3390/ijms231810930
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions
2025 · Cancer Cell · 6 citations
https://doi.org/10.1016/j.ccell.2025.10.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat